JIANPU TECHNOLOGY INC-SP ADR (JT)

US47738D3098 - ADR

0.7799  +0.06 (+7.78%)

After market: 0.76 -0.02 (-2.55%)

Fundamental Rating

1

JT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 51 industry peers in the Consumer Finance industry. JT may be in some trouble as it scores bad on both profitability and health. JT has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

JT had negative earnings in the past year.
In the past 5 years JT always reported negative net income.
In the past 5 years JT always reported negative operating cash flow.

1.2 Ratios

JT's Return On Assets of -5.01% is on the low side compared to the rest of the industry. JT is outperformed by 77.36% of its industry peers.
The Return On Equity of JT (-11.42%) is worse than 75.47% of its industry peers.
Industry RankSector Rank
ROA -5.01%
ROE -11.42%
ROIC N/A
ROA(3y)-18.01%
ROA(5y)-17.59%
ROE(3y)-37.96%
ROE(5y)-33.36%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

JT's Gross Margin of 24.17% is on the low side compared to the rest of the industry. JT is outperformed by 62.26% of its industry peers.
In the last couple of years the Gross Margin of JT has declined.
The Profit Margin and Operating Margin are not available for JT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.14%
GM growth 5Y-24.93%

3

2. Health

2.1 Basic Checks

JT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JT remains at a similar level compared to 1 year ago.
The number of shares outstanding for JT has been increased compared to 5 years ago.
The debt/assets ratio for JT is higher compared to a year ago.

2.2 Solvency

JT has an Altman-Z score of -0.67. This is a bad value and indicates that JT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.67, JT is not doing good in the industry: 71.70% of the companies in the same industry are doing better.
JT has a Debt/Equity ratio of 0.60. This is a neutral value indicating JT is somewhat dependend on debt financing.
JT has a better Debt to Equity ratio (0.60) than 75.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z -0.67
ROIC/WACCN/A
WACC6.34%

2.3 Liquidity

A Current Ratio of 1.67 indicates that JT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.67, JT is in the better half of the industry, outperforming 64.15% of the companies in the same industry.
JT has a Quick Ratio of 1.67. This is a normal value and indicates that JT is financially healthy and should not expect problems in meeting its short term obligations.
JT has a better Quick ratio (1.67) than 64.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.76% over the past year.
Looking at the last year, JT shows a very negative growth in Revenue. The Revenue has decreased by -10.33% in the last year.
JT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.30% yearly.
EPS 1Y (TTM)77.76%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q60.43%
Revenue 1Y (TTM)-10.33%
Revenue growth 3Y-11.66%
Revenue growth 5Y-7.3%
Revenue growth Q2Q-4.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JIANPU TECHNOLOGY INC-SP ADR

NYSE:JT (2/20/2024, 7:04:00 PM)

After market: 0.76 -0.02 (-2.55%)

0.7799

+0.06 (+7.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap16.55M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.01%
ROE -11.42%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 24.17%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)77.76%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-10.33%
Revenue growth 3Y-11.66%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y